CD274 and plasma cell myeloma: Although the impact of lenalidomide on programmed death 1 (PD-1)/PD-L1 expression has not been specifically reported in patients with FL, it has been reported to downregulate PD-L1 expression on plasma cells and to downregulate PD-1 expression on T cells in multiple myeloma [22].